Cancer drug joins list of medicines in short supply

Nov 14 2011

Los Angeles Times: Cancer Drug Doxil Joins Growing List Of Drugs In Short Supply
A crucial cancer drug has been in short supply since midsummer -; and its maker, Johnson & Johnson Inc., has not been able to remedy the situation since. The medicine, Doxil, is used to treat patients with ovarian cancer, multiple myeloma or Kaposi's sarcoma after first-line treatments have failed (Adams, 11/14). 

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , , , ,

Comments (0)

Suggested Reading

Creating CAR-T cells with enhanced immune memory to fight cancer
New trial shows promise of combination neoadjuvant immunotherapy for lung cancer
Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy
Study reveals key reproductive factors that may increase lung cancer risk in women
Air pollution fueling a spike in breast cancer risk
Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine
The anti-metastatic and anti-proliferation impact of dandelion extract on breast cancer cells
Robust detection of gallbladder cancer using deep-learning-assisted US imaging

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »
You might also like...
Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug